Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) — Free Cash Flow Generation Index
Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) has a Free Cash Flow Generation Index of 0.94x as of September 2025. Free cash flow of CN¥71.38 Million represents 1% of operating cash flow (CN¥76.07 Million). Explore reinvestment intensity of Beijing Sun Novo Pharmaceutical Research to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Beijing Sun Novo Pharmaceutical Research Co Ltd Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Beijing Sun Novo Pharmaceutical Research Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see 688621 cash flow conversion.
Annual Free Cash Flow Generation for Beijing Sun Novo Pharmaceutical Research Co Ltd (2017–2025)
Year-by-year Free Cash Flow Generation Index for Beijing Sun Novo Pharmaceutical Research Co Ltd. Check 688621 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | CN¥50.78 Million | CN¥93.21 Million | CN¥42.43 Million | ▲ +1035.9% |
| 2024 | 0.05x | CN¥1.54 Million | CN¥32.02 Million | CN¥30.48 Million | ▼ -77.6% |
| 2023 | 0.21x | CN¥19.90 Million | CN¥92.86 Million | CN¥72.96 Million | ▲ +24139.9% |
| 2022 | 0.00x | CN¥91.92K | CN¥103.96 Million | CN¥103.87 Million | ▼ -97.6% |
| 2021 | 0.04x | CN¥3.29 Million | CN¥88.25 Million | CN¥84.96 Million | ▼ -93.5% |
| 2020 | 0.57x | CN¥35.96 Million | CN¥62.99 Million | CN¥27.03 Million | ▲ +3.9% |
| 2019 | 0.55x | CN¥31.30 Million | CN¥56.97 Million | CN¥25.67 Million | ▼ -12.5% |
| 2018 | 0.63x | CN¥27.70 Million | CN¥44.11 Million | CN¥16.41 Million | ▲ +138.9% |
| 2017 | -1.62x | CN¥-12.94 Million | CN¥8.01 Million | CN¥20.96 Million | — |